Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$20.93M$20.93Mderived−7.0% vs Q4 2017 Net Income$19.74M$19.74Mderived+419.4% vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$5,710,000−16.8% Operating Incomederived$1,067,000−48.0% Operating Cash Flowderived$3,355,000−7.1% Free Cash Flowderived$1,164,000−63.5% Margins · derivedGross margin27.3%−3.2 pt vs Q4 2017
Operating margin5.1%−4.0 pt vs Q4 2017
Net margin94.3%+77.5 pt vs Q4 2017
ended Dec 31, 2018 · filed Feb 7, 2019 · 38 d after period end